Inotec AMD, a Cambridge based, fast-growing medtech business that has developed a novel device capable of healing complex chronic wounds, has secured investment of £7m. The funding round was led by Praetura Capital, with involvement from Boundary Capital.

The business has developed a world leading medtech product, called NATROX® Oxygen, for use in Wound Therapy. It generates pure humidified oxygen to treat a range of chronic wounds, from diabetic and venous ulcers to non-healing surgical wounds.